Abstract:The nitrate/nitrite response regulatory protein NarL belongs to the two-component regulatory system of <i>Mycobacterium tuberculosis</i> (MTB), plays a crucial role in anaerobic survival of mycobacteria in host. The absence of this protein in humans, makes it an attractive drug target for MTB treatment. However, the specific drug molecules targeting NarL are yet to be identified. In this study, we identified the promising drug candidates using structure based virtual screening of compounds from chemical libraries (ChEMBL and ZINC), followed by the extensive physicochemical properties analyses and molecular dynamics (MD) simulation. As the initial results, we obtained 4,754 bioactive compounds from ChEMBL having anti-tuberculosis activity which is finally narrowed down to the best 10 hits. A similar approach was applied to search for structurally similar compounds from ZINC data, corresponding to the top hits obtained from ChEMBL. Our collective results show that two compounds, ChEMBL509609 (Gscore – 5.054 kcal/mol, Xscore – 6.47 kcal/mol) and ZINC01843143 (Gscore – 5.114 kcal/mol, Xscore – 6.46 kcal/mol) having the best docking score and ADMET profile. The structural stability and dynamics of lead molecules at active site of NarL were examined using MD simulation and the binding free energies were estimated with MM-PBSA. Essential dynamics and MM-PBSA demonstrated that NarL-ChEMBL509609 complex remains the most stable during simulation of 100 ns with the higher binding free energy which may be a suitable candidate for further experimental analysis. Absorption, Distribution, Metabolism, And ExcretionBacillus Calmette-GuerinCentral nervous systemDirectly observed treatment, short courseEssential dynamicsHuman immunodeficiency virusHistidine kinaseHuman oral absorptionHigh throughput virtual screeningIrritationMolecular dynamicsMultidrug resistant<i>Mycobacterium tuberculosis</i>MutagenicityMolecular weightPercentage of human oral absorptionReproductive developmentRadius of gyrationRoot mean square deviationRoot mean square fluctuationLipinski's rule of fiveResponse regulatorStandard precisionStandard precision glideTuberculosisTwo-component regulatory systemTotally drug-resistantTumorigenicityWorld health organizationExtensively drug-resistantExtra precisionCommunicated by Ramaswamy H. Sarma

Fluorescence-based Visual Analysis and Inhibitor Screening of Arylamine N-acetyltransferase 2, a Key Enzyme for Tuberculosis

Anti-mycobacterial natural products and mechanisms of action

Computational screening of natural MtbDXR inhibitors for novel anti-tuberculosis compound discovery

Bioinformatic Approaches Identify Hybrid Antibiotics against Tuberculosis via d-Amino Acid-Activating Adenylation Domains from Cordyceps militaris

High-throughput fluorescent screening of β-lactamase inhibitors to improve antibiotic treatment strategies for tuberculosis

Recent developments in natural product-based drug discovery for tuberculosis

Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis

Identification of bioactive compounds Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening

High-throughput fluorescent screening of thioredoxin reductase inhibitors to inhibit Mycobacterium tuberculosis

Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B

A Novel Inhibitor Of Indole-3-Glycerol Phosphate Synthase With Activity Against Multidrug-Resistant Mycobacterium Tuberculosis

Seeing is believing: Efficiency evaluation of multifunctional ionic-dependent AIEgens for tuberculosis

Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates

Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach

Identification of BMVC-8C3O As a Novel Pks13 Inhibitor with Anti-Tuberculosis Activity

Real-Time Imaging Of Mycobacterium Tuberculosis, Using A Novel Near-Infrared Fluorescent Substrate

A High-Throughput Screen against Pantothenate Synthetase (PanC) Identifies 3-Biphenyl-4-Cyanopyrrole-2-Carboxylic Acids as a New Class of Inhibitor with Activity against Mycobacterium tuberculosis

The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents

In Vivo and in Silico Investigation of Selected Herbal Compounds As Anti-Tubercular Agents

Integrated virtual screening and MD simulation study to discover potential inhibitors of mycobacterial electron transfer flavoprotein oxidoreductase

Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides